|
Stocks Achieving 52-Week Highs As Markets Lack Direction
Wall St. Cheat Sheet Insmed's primary focus is on the development of inhaled antibiotic therapy delivered via proprietary advanced pulmonary liposome technology in areas of high unmet need in lung diseases. Competitors to Watch: Pfizer Inc. (NYSE:PFE), Bristol Myers Squibb ... |
Read the full story:
Stocks Achieving 52-Week Highs As Markets Lack Direction - Wall St. Cheat Sheet
You must log in to post a comment.